These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34362613)

  • 1. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2021 Aug; ():. PubMed ID: 34362613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness.
    Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of left atrial appendage closure in patients on anticoagulation for atrial fibrillation and recurrent or chronic gastrointestinal bleeding.
    Gonzalez-Gonzalez L; Calm A; Mañosa M; Bazán V; Borrellas A; Carrillo X; Bisbal F; Vallejo N; Cañete F; Calafat M; Domènech E
    Gastroenterol Hepatol; 2023 Oct; 46(8):621-627. PubMed ID: 36828118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease.
    Lind A; Azizy O; Lortz J; Janosi A; Rassaf T; Rammos C
    Arch Med Sci; 2023; 19(2):331-336. PubMed ID: 37034526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation.
    Fayos-Vidal F; Arzamendi-Aizpurua D; Millán-Álvarez X; Guisado-Alonso D; Camps-Renom P; Prats-Sánchez L; Martínez-Domeño A; Delgado-Mederos R; Martí-Fàbregas J
    Neurologia (Engl Ed); 2020; 35(1):10-15. PubMed ID: 28865942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device.
    Luani B; Genz C; Herold J; Mitrasch A; Mitusch J; Wiemer M; Schmeißer A; Braun-Dullaeus RC; Rauwolf T
    BMC Cardiovasc Disord; 2019 May; 19(1):112. PubMed ID: 31092201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.
    Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J
    Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of left atrial appendage closure efficacy and outcomes by CHA
    Zhao M; Zhao M; Hou CR; Post F; Herold N; Walsleben J; Yuan Q; Meng Z; Yu J
    Front Cardiovasc Med; 2022; 9():905728. PubMed ID: 35935622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis.
    Flores-Umanzor E; Asghar A; Cepas-Guillén PL; Farrell A; Keshvara R; Alvarez-Rodriguez L; Osten M; Freixa X; Horlick E; Abrahamyan L
    Clin Res Cardiol; 2024 Oct; 113(10):1485-1500. PubMed ID: 38112741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience.
    Xipell M; Flores-Umanzor E; Ojeda R; Arias M; Cepas-Guillén PL; Regueiro A; Freixa X; Cases A; Maduell F
    Artif Organs; 2020 May; 44(5):513-521. PubMed ID: 31715006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left atrial appendage closure in patients with prior intracranial bleeding and thromboembolism.
    Pouru JP; Lund J; Jaakkola S; Vasankari T; Biancari F; Saraste A; Airaksinen KEJ
    Heart Rhythm; 2020 Jun; 17(6):915-921. PubMed ID: 32036026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention.
    Yu Y; Xu J; Wang L; Ye Z; Chen Z; Chen F
    BMC Cardiovasc Disord; 2022 Oct; 22(1):433. PubMed ID: 36192682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Glomerular Filtration Rates on Outcomes Following Percutaneous Left Atrial Appendage Closure.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Am J Cardiol; 2021 Apr; 145():77-84. PubMed ID: 33508268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
    Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
    Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.